FDA approves Israeli IceCure tumor-treating tech for liver, kidney cancer

Good News Notes:

“IceCure, a Tel Aviv-based medical device company has received additional US Food and Drug Administration approval for its tumor-treating cryoablation technology.

In an interview with The Jerusalem Post on Thursday, Tlalit Bussi Tel Tzure, IceCure’s vice president of business development and global marketing, said the company received its first approval by the FDA in 2010 following clinical trials and evaluations. The company was founded in 2006.”

View the whole story here: https://www.jpost.com/HEALTH-SCIENCE/Israeli-tech-firm-specializing-in-freezing-tumors-gains-FDA-approval-in-US-613687

Leave a Reply